Limitations of homologous recombination status testing and poly (ADP-ribose) polymerase inhibitor treatment in the current management of ovarian cancer

Overview of attention for article published in Frontiers in oncology, July 2024

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 1 Mendeley

So far, Altmetric has seen 1 X post from an account with 6,551 followers.

New Research: Limitations of homologous recombination status testing and poly (ADP-ribose) polymerase inhibitor treatment in the current management of ovarian cancer https://t.co/SEnKhlfuL7 #FrontiersIn #Oncology

22 Jul 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.